Koyfin Home > Directory > Health Care > Aimmune Therap > Repurchase of Common Stock

Aimmune Therap Repurchase of Common Stock Chart (AIMT)

Aimmune Therap annual/quarterly Repurchase of Common Stock from 2015 to 2020.
  • Aimmune Therap Repurchase of Common Stock for the quarter ending June 06, 2020 was $0m a 100.00% decrease of 0m year over year
  • Aimmune Therap Repurchase of Common Stock for the last 12 months ending June 06, 2020 was $-2m a 56.90% decrease of -1m year over year
Other Cash Flow Metrics:
  • Aimmune Therap Cash Flow from Operations for the quarter ending September 09, 2018 was $-41m a 22.62% decrease of -9m year over year
  • Aimmune Therap Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-25m a 30.11% decrease of -7m year over year
View Chart On Koyfin

Quarterly AIMT Repurchase of Common Stock Data

06/2020$0m
03/2020$-1m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
12/2015$0m

Annual AIMT Repurchase of Common Stock Data

2019$-1m